On June 11, 2024, the Institute of Chinese Medical Sciences (ICMS) and the State Key Laboratory of Quality Research in Chinese Medicine (SKLQRCM) at the University of Macau (UM)
Distinguished Professor Chen Xin, the Dean of the Institute of Chinese Medical Sciences (ICMS) and the Director of the State Key Laboratory of Quality Research in Chinese Medicine (SKLQRCM) at the University of Macau (UM), along with Associate Professor Lu Jiahong, the Vice Dean, and Professor Wan Jianbo, the Assistant Dean, visited the Tianjin Institute of Industrial Biotechnology (TIB), Chinese Academy of Sciences (CAS), for an exchange and discussion. The meeting was chaired by Tian Chaoguang, Deputy Director of TIB.
During the meeting, Tian Chaoguang introduced the overall situation and recent progress in technological innovation at TIB, while Chen Xin presented an overview of UM, as well as the progress of ICMS and SKLQRCM. The two sides engaged in in-depth discussions on accelerating the innovative development of synthetic biology in traditional Chinese medicine, including advancing the construction of joint laboratories, promoting talent cultivation, academic exchanges, and technology transfer.
In his concluding remarks, Xiang Hua, Legal representative and Deputy Director of TIB pointed out that traditional Chinese medicine is a strategic resource for the country. TIB has significant advantages in the microbial recombination synthesis of key components in traditional Chinese medicine, while ICMS has a profound foundation in the evaluation of traditional Chinese medicine’s efficacy and quality research. The ongoing establishment of a joint laboratory for synthetic biology in traditional Chinese medicine reflects the concept of complementing disciplinary advantages and holds great significance for the inheritance, innovation, and high-quality development of traditional Chinese medicine resources. Chen Xin expressed that UM attaches great importance to cooperation with TIB and looks forward to deepening collaboration, leveraging respective strengths, and jointly promoting innovation, talent cultivation, and technology transfer in the field of synthetic biology in traditional Chinese medicine.
During the visit, Professor Chen Xin and his delegation also visited the technology achievement exhibition hall and the overall research department of the institute. This discussion further enhanced mutual understanding and laid an important foundation for future extensive collaboration in industry-academia-research cooperation and the integration of science and education.
